Table of Contents
This robotics patent due diligence case study follows a strategic acquirer through the IP audit it ran before buying a warehouse-automation company, and shows why the patent count on a target’s pitch deck is almost never the number that matters. Robotics is one of the most active corners of the patent system: WIPO’s World Intellectual Property Indicators 2025 recorded 3.7 million patent applications filed worldwide in 2024, up 4.9% year on year, with computer technology — the field that now drives autonomous robotics — the single largest area at 13.2% of global filings. In a field filing that fast, a target can look dominant and still own far less than the buyer thinks.
The scenario below shows the exact sequence PerspireIP runs in an M&A IP due diligence engagement, the public data it is built on, and the two findings that changed the deal — a repriced purchase and a title problem the seller had to fix before closing.
The Challenge: A Robotics Portfolio That Underpinned the Whole Thesis
The client, a large materials-handling group, had a signed letter of intent to acquire a venture-backed warehouse-robotics company. The target’s value story rested almost entirely on intangible assets — its picking-arm control software, its fleet-orchestration methods, and the patent family it described as “foundational” to autonomous case handling. That is not unusual: Ocean Tomo’s Intangible Asset Market Value Study found intangible assets grew from 17% of S&P 500 market value in 1975 to roughly 90% by 2020, so in a technology acquisition the IP frequently is the deal.
Three questions from the acquirer’s board had to be answered before signing. Does the target actually own what it claims? Is any of it encumbered? And is the “foundational” family really foundational, or is it a defensible-looking wrapper around crowded prior art?
Those questions are hard in robotics specifically. The field is crowded with fast-moving specialists — Patsnap’s industrial-robotics landscape shows recent-filing momentum led by assignees such as Dexterity (up 177% versus the prior window), Ocado Innovation and ABB, with established players filing heavily and startups filing fast and messily. A target that has raised three rounds, hired across four countries and acquired a smaller competitor along the way tends to accumulate exactly the kind of chain-of-title debris that only surfaces when someone checks the assignment records against the cap table.
Our Robotics Patent Due Diligence Approach: Five Stages
PerspireIP structured the robotics patent due diligence as five sequential stages, each moving from “what the target says it owns” toward “what a court and a competitor would agree it owns.” The method is the same diligence sequence described on our M&A IP diligence service page, applied to the robotics and automation sector we cover on our robotics market-research page.
- Portfolio inventory. We reconciled the target’s asset schedule against primary records — USPTO, EPO Espacenet, WIPO PATENTSCOPE and the relevant national registers — deduplicated to the family level, and separated granted patents from pending applications, provisionals and abandoned matter. The schedule listed more assets than the registers supported once expired and abandoned cases were removed.
- Chain-of-title verification. For every in-scope family we traced ownership from named inventor to the target entity: employee assignment agreements, contractor IP clauses, the recorded assignments in the USPTO Assignment database, and the paperwork from the target’s own earlier acquisition. Under 35 U.S.C. § 261 an unrecorded assignment is void against a later bona-fide purchaser who records first, so an unrecorded link is not a formality — it is a live risk.
- Landscape and validity screen. We benchmarked the “foundational” family against the wider robotics landscape — the assignee neighbourhood of Dexterity, Ocado, ABB, Mitsubishi Electric and the university filers — and pulled the closest prior art to test how much room the independent claims really had.
- Valuation range. We valued the portfolio on the income and market approaches rather than the target’s cost narrative, tying value to licensable claims and comparable robotics transactions instead of R&D spend.
- Deal-risk readout. Findings were translated into red-flag, price-adjustment and closing-condition buckets for transaction counsel — the form corporate development could take straight into the negotiation.
What the Diligence Surfaced
Reconciling the story against the registers changed the picture materially:
- The asset count was inflated. Once abandoned applications and two lapsed families (missed maintenance fees) were removed, the portfolio was smaller than the schedule claimed — not fatal, but the first sign the schedule had not been maintained against the registers.
- Nine assignments were never recorded. Nine families — including inventions from contractors and two from the target’s own earlier acquisition — had signed assignments in the data room but nothing recorded at the USPTO. Three of those sat inside the “foundational” family, meaning the target could not cleanly prove it owned its own crown jewels.
- The foundational family was narrower than sold. The independent claims of the core family read onto a control method already disclosed in earlier third-party art; the genuinely novel matter sat in the dependent claims. The family was real and useful, but it was a picket fence, not a moat — and priced as a moat.
- One geography was exposed. The target had filed in the U.S. and the EPO but let the PCT national-phase deadline lapse in two markets where the acquirer planned to deploy first, leaving those markets unprotected.
The Outcome: A Repriced, De-Risked Deal
The diligence did not kill the deal — it made it a deal the board could actually approve. With the findings in hand, the acquirer was able to:
- Negotiate a $14M purchase-price adjustment reflecting the narrower core family and the smaller clean-title asset base, supported by evidence rather than a haggle.
- Make recordation of the nine assignments a condition precedent to closing, so the seller — not the buyer — carried the cost and effort of perfecting title before the money moved.
- Add specific IP representations and a targeted indemnity for the chain-of-title and prior-art findings, converting unknown exposure into allocated risk.
- Redirect post-close budget toward continuation filings on the genuinely novel dependent matter and re-filing in the two lapsed markets, turning a weakness surfaced in diligence into a filing plan.
The difference was between a buyer paying moat prices for a picket fence and a buyer who knew exactly what it was buying — the kind of proof an investment committee and a purchase agreement both require.
Lessons for Acquirers Buying Robotics IP
- Check the registers, not the schedule. A target’s asset list is a marketing document; the USPTO, EPO and PCT registers are the record. Reconcile every family before you price anything.
- Unrecorded assignments are a live risk, not paperwork. Under 35 U.S.C. § 261 an unrecorded assignment can be void against a later purchaser — make recordation a closing condition, not a post-close chore.
- Read the independent claims of the “foundational” patent. Value lives in claim scope, not in the word “foundational.” Test the core family against prior art before you accept the moat narrative.
- Map geography to the deployment plan. A robotics portfolio that lapses in the very markets the buyer plans to enter first is worth less than its family count suggests.
Data Sources
The market and patent data referenced above comes from:
- WIPO — World Intellectual Property Indicators 2025 (Patents Highlights) — 3.7 million patent applications filed worldwide in 2024 (+4.9%); computer technology the largest field at 13.2% of filings; 2.1 million patents granted.
- Ocean Tomo (a part of J.S. Held) — Intangible Asset Market Value Study — Intangible assets rose from 17% of S&P 500 market value in 1975 to roughly 90% by 2020 and about 92% by 2025 — in technology M&A, IP is the deal.
- Patsnap — Robotics Technology & Industrial Robot Patent Landscape — Recent-filing momentum led by Dexterity (+177% vs prior window), Ocado Innovation and ABB; the US leads robotics filing jurisdictions.
- 37 CFR 3.11 & 35 U.S.C. 261 — USPTO assignment recordation — An assignment is void against a subsequent bona-fide purchaser unless it is recorded within the statutory window — the legal basis for chain-of-title diligence.
Buying or Selling a Robotics Company?
Get an M&A IP due diligence review that reconciles the target’s portfolio against the registers — before you price the deal.
Buying or Selling a Robotics Company?
Frequently Asked Questions
What is robotics patent due diligence?
Robotics patent due diligence is the pre-deal audit of a robotics or automation target’s patents and applications: verifying what the target actually owns, whether title is clean and recorded, how strong the core claims are against prior art, and what the portfolio is worth. It replaces the target’s asset schedule with a reconciliation against the USPTO, EPO and WIPO registers.
Why does chain of title matter so much in an acquisition?
Because under 35 U.S.C. § 261 an unrecorded assignment can be void against a later bona-fide purchaser who records first. If the target never recorded assignments from inventors, contractors or a prior acquisition, the buyer may not receive clean ownership of the very patents it is paying for — which is why recordation is commonly made a condition of closing.
How is a robotics patent portfolio valued for M&A?
Most robotics portfolios are valued on the income approach (the licensable cash flows the claims can support, often via a relief-from-royalty calculation) and cross-checked against the market approach (comparable robotics transactions). The cost approach — what the R&D cost to create — is the weakest indicator because development spend has little relationship to a patent’s earning power or claim scope.
What are the most common IP red flags in a robotics deal?
The recurring ones are unrecorded or missing assignments, abandoned or lapsed families still listed as assets, a ‘foundational’ patent whose independent claims read onto prior art, missed PCT national-phase deadlines in key markets, and open-source or joint-development obligations that encumber the code driving the robots.
How long does robotics patent due diligence take?
A focused portfolio audit for a mid-size robotics target typically runs on a deal timeline of a few weeks, scaled to portfolio size and the number of jurisdictions. The inventory and chain-of-title stages come first so red flags surface early enough to shape price and closing conditions rather than after signing.